| Phase 07 trials |
|
Phase 0
|
NCT07528105 |
Apr 2026 → Dec 2027 expected |
type 1 diabetes mellitus |
Shanghai Zhongshan Hospital |
Recruiting
|
No outcome recorded
|
|
Phase 0
|
NCT07142161 |
Jul 2025 → Jul 2026 overdue |
type 1 diabetes mellitus |
Nanjing Bioheng Biotech Co., Ltd. |
Active not recruiting
|
No outcome recorded
|
|
Phase 0
|
NCT05923541 |
Jun 2023 → Aug 2024 |
hematopoietic and lymphoid cell neoplasm |
Henan Cancer Hospital |
Completed
|
No outcome recorded
|
|
Phase 0
|
NCT05902845 |
Apr 2023 → Aug 2024 |
hematopoietic and lymphoid cell neoplasm |
Xiaoyu Zhu |
Completed
|
No outcome recorded
|
|
Phase 0
|
NCT05895994 |
Mar 2023 → Dec 2024 |
hematopoietic and lymphoid cell neoplasm |
MEI HENG |
Completed
|
No outcome recorded
|
|
Phase 0
|
NCT05907603 |
Mar 2023 → Aug 2024 |
hematopoietic and lymphoid cell neoplasm |
Kai Lin Xu，MD |
Completed
|
No outcome recorded
|
|
Phase 0
|
NCT05716113 |
Feb 2023 → Aug 2024 |
hematopoietic and lymphoid cell neoplasm |
He Huang |
Completed
|
No outcome recorded
|
| Phase 12 trials |
|
Phase 1
|
NCT06622694 |
Jun 2025 → Oct 2026 expected |
aplastic anemia |
Institute of Hematology & Blood Diseases Hospital, China |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT06732492 |
Oct 2024 → Dec 2026 expected |
mature T-cell and NK-cell non-Hodgkin lymphoma, refractory hematologic cancer |
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
Recruiting
|
No outcome recorded
|